Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Sopheon PLC New Release of Award-winning Innovation Product 01/09/2022 7:02am RNS Non-Regulatory TIDMSPE Sopheon PLC 01 September 2022 SOPHEON PLC ("Sopheon" or the "Company") New Release of Award-winning Innovation Product Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, today announced a series of enhancements and additions to its award-winning innovation management product, Accolade(R). Sopheon customers will benefit from stronger collaboration capabilities, expanded data metrics, and additional financial modeling, all within a highly secure environment. Using Accolade, Sopheon's long-standing blue-chip customers across a diverse range of industries have experienced superior strategy-to-execution performance, reduced time-to-market, improved efficiency, and greater product success rates. Benefits of the latest enhancements include: -- Greater team collaboration with standardized access to timely communication and smooth transitions -- Increased financial data metrics that leverage integration with ROI Blueprints, acquired by Sopheon in December -- Improved portfolio navigation between multiple projects within a portfolio to assist decision making -- Expanded authentication with OpenID Connect, a protocol used by a variety of security access identity providers "Successful innovation is driven by collaboration, context and clear communication around new and product-line extension initiatives," said Michael Bauer, chief product officer of Sopheon. "By addressing all three areas with our latest enhancements and strengthening our security and out of the box financial capabilities, companies innovating with Accolade and other Sopheon innovation management products will experience greater efficiencies and faster time to value." Sopheon's leadership in innovation management was highlighted in the comprehensive MarketsandMarkets(TM) report on the Innovation Management Market. Sopheon was listed in the "Stars" category, the highest recognition. Sopheon was described as one of the leading players in the innovation management market thanks to the company's "robust and wide range of products and solutions in the innovation management category." Sopheon is in a select ranking alongside other leaders, such as Accenture, SAP and KPMG.
Alweer koopt iemand op de valreep 2 stuks ( 2 sept. 17:29, à 635). Vorige week ook. Is er iemand die weet wat hier achter zit?
We hadden het altijd over het gebrek aan commercieel gevoel, het niet laten weten dat het bedrijf bestaat. Dit is in mijn beleving wel een heel aparte "ommezwaai". Geen idee wat hier dan mee bedoeld wordt, maar we zullen het gaan zien. Het zet in ieder geval aan het denken!
Tritace schreef op 15 september 2022 08:14 :
??
Dit stond enige tijd geleden ook op Linkedin. Heeft er nog geen paar uur opgestaan. Ik zag het toevallig. Gr Arie de Beuker
Tritace schreef op 15 september 2022 08:14 :
??
Hallo Tritsce, In een antwoord er onder staat dat ze volgende week het nieuws bekend maken. Niet iets koersgevoeligs dus. Groet ABC.
De website is wel vernieuwd
abc123xyz987 schreef op 15 september 2022 15:21 :
[...]
Hallo Tritace,
In een antwoord er onder staat dat ze volgende week het nieuws bekend maken. Niet iets koersgevoeligs dus.
Groet ABC.
Deze week dus. Ik ben benieuwd. Gr Arie de Beuker
Misschien een update ergens van! Maar wel benieuwd wat het kan zijn, partnerschap misschien!
Sopheon launches Acclaim line of SaaS offerings Sopheon, the leading international provider of software and services for Innovation Management, today announced the launch of Acclaim™, three software-as-a-service (SaaS) products designed to maximize performance across the ideas, product, and project spectrum. Sopheon’s comprehensive innovation management offerings cover the full scope of jobs that product, innovation, and project professionals need to accomplish their objectives. Three new dynamic Acclaim solutions—Acclaim Ideas (formerly Solverboard), Acclaim Projects (formerly ROI Blueprints), and Acclaim Products—each offer unique capabilities and benefits, delivering comprehensive collaboration from the front-end of innovation to delivery. These new products give individuals responsible for idea generation, product management, and project management tighter control and an improved ability to make better data-driven decisions. Sopheon makes it easy for organizations to get started by offering free versions of the Acclaim offerings, as well as paid subscriptions for more advanced features and functionality. The launch of these new solutions significantly expands Sopheon’s addressable market and competitive advantage. “Innovation is indispensable to an organization’s long-term success,” said Greg Coticchia, CEO of Sopheon. “Technology advances and the global sustainability movement are adding to the pressures on today’s managers, who are constantly seeking ways to deliver better products and processes. The launch of the Acclaim offerings furthers Sopheon’s vision to help executives, team leaders, and individual contributors improve their productivity and actively engage in driving innovation forward. Sopheon is uniquely positioned to help companies achieve exceptional long-term growth and profitability through sustainable innovation.” In the past nine months, Sopheon has acquired ROI Blueprints and Solverboard. The new Acclaim offerings will integrate those technologies and functionalities with Accolade®, Sopheon’s award-winning innovation management software. Together, Sopheon's new cloud product offerings mitigate risk by providing accountability, visibility, and control to tie strategy to the successful execution of an organization's innovation lifecycle.www.sopheon.com/investors/rns-release...
Mooie uitbreiding, zat er aan te komen. Benieuwd wat voor impact dit op de omzet gaat hebben.
Hoi Tritace, waarschijnlijk was dit dus het nieuws. Strategische zet. Gr Arie de Beuker
Helaas doet het niets met de koers, nog een lange weg te gaan richting die ooit zo mooie 12 pond....
Gartje dat waren hele mooie tijden. Groet Trinko
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
905,10
+0,16%
EUR/USD
1,0909
+0,57%
FTSE 100
8.262,75
-0,15%
Germany40^
18.571,90
-0,19%
Gold spot
2.351,38
+0,02%
NY-Nasdaq Composite
16.828,67
+0,56%
Stijgers
Dalers